WHO receives first-ever donation of insulin

The World Health Organization (WHO) announced Friday that Novo Nordisk has donated $1.3 million worth of insulin and glucagon. The donation will benefit 50 low- and middle-income countries. "For many people living with diabetes these are difficult times," said Prof. Andrew Boulton, president of the International Diabetes Federation.

The World Health Organization (WHO) announced Friday that Novo Nordisk has donated $1.3 million worth of insulin and glucagon. The donation will benefit 50 low- and middle-income countries. "For many people living with diabetes these are difficult times," said Prof. Andrew Boulton, president of the International Diabetes Federation. "They are both vulnerable to the severe effects of COVID-19 and struggling with day-to-day problems managing their diabetes, such as disrupted access to medication, equipment and health care. Initiatives to secure the supply of essential diabetes medicines, and of insulin in particular, are very welcome." This is the first donation to the WHO of a medication for a noncommunicable disease, according to Bente Mikkelsen, director of the WHO's Department of Noncommunicable Diseases. Countries set to receive the donated insulin were selected based on their income group and information provided to WHO by ministries of health on the capacity of their health systems to manage storage and supply when transport systems and health care systems have been challenged. Novo Nordisk's donation comes just months after insulin was included in the WHO's prequalification program.